ArticleCancer immunology, immunotherapy : CII2010

Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity.

Norimasa Matsushita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.